Sale!

ERCC2 Gene Xeroderma Pigmentosum Group D Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ERCC2 Gene Xeroderma Pigmentosum Group D Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the ERCC2 gene, which are implicated in Xeroderma Pigmentosum (XP), particularly in Group D. This condition is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) rays from sunlight, leading to a higher risk of skin cancers and premature skin aging. The test, priced at 4400 AED, is crucial for early detection and management of XP, enabling personalized care plans and preventive measures to be put in place for affected individuals. By analyzing an individual’s DNA sample, the test provides valuable insights into their genetic predisposition to XP Group D, facilitating informed decisions regarding their health and lifestyle.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ERCC2 Gene Xeroderma pigmentosum group D Genetic Test

Components:

  • Test Name: ERCC2 Gene Xeroderma pigmentosum group D Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for ERCC2 Gene Xeroderma pigmentosum, group D NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERCC2 Gene Xeroderma pigmentosum, group D NGS Genetic DNA Test gene ERCC2.

Test Details:

The ERCC2 gene is associated with a disorder called xeroderma pigmentosum, group D (XP-D). XP-D is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) radiation from the sun and an increased risk of developing skin cancer. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of ERCC2 gene testing for XP-D, NGS can be used to identify mutations or variations in the ERCC2 gene that may be responsible for the disorder. NGS genetic testing for ERCC2 gene mutations in XP-D can help confirm a diagnosis, provide information about disease severity, guide treatment decisions, and assess the risk of developing skin cancer. It can also be used for carrier testing and family planning purposes. It is important to consult with a healthcare professional or a genetic counselor to discuss the benefits, limitations, and implications of genetic testing for ERCC2 gene mutations in XP-D. They can provide guidance on whether testing is appropriate, help interpret the results, and discuss available treatment options and management strategies.

Test Name ERCC2 Gene Xeroderma pigmentosum group D Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ERCC2 Gene Xeroderma pigmentosum, group D NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERCC2 Gene Xeroderma pigmentosum, group D NGS Genetic DNA Test gene ERCC2
Test Details

The ERCC2 gene is associated with a disorder called xeroderma pigmentosum, group D (XP-D). XP-D is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) radiation from the sun and an increased risk of developing skin cancer.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of ERCC2 gene testing for XP-D, NGS can be used to identify mutations or variations in the ERCC2 gene that may be responsible for the disorder.

NGS genetic testing for ERCC2 gene mutations in XP-D can help confirm a diagnosis, provide information about disease severity, guide treatment decisions, and assess the risk of developing skin cancer. It can also be used for carrier testing and family planning purposes.

It is important to consult with a healthcare professional or a genetic counselor to discuss the benefits, limitations, and implications of genetic testing for ERCC2 gene mutations in XP-D. They can provide guidance on whether testing is appropriate, help interpret the results, and discuss available treatment options and management strategies.